Evidence map›Paper›PMID 25879037›Full record

ArticleBioMed research international2015

Ghrelin improves functional survival of engrafted adipose-derived mesenchymal stem cells in ischemic heart through PI3K/Akt signaling pathway.

Dong Han, Wei Huang, Sai Ma, Jiangwei Chen, Lina Gao, Tong Liu, Rongqing Zhang, Xiujuan Li, Congye Li, Miaomiao Fan and 2 more

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Physiological Effect of Ghrelin on Body Systems.International journal of endocrinology · 2020
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Ghrelin and gastrointestinal stromal tumors.World journal of gastroenterology · 2017
    Review
  17. Article
  18. Stem cell death and survival in heart regeneration and repair.Apoptosis : an international journal on programmed cell death · 2016
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Dong HanDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Wei HuangDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Sai MaDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Jiangwei ChenDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Lina GaoDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Tong LiuDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Rongqing ZhangDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Xiujuan LiDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Congye LiDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Miaomiao FanDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Yundai ChenDepartment of Cardiology, Chinese PLA General Hospital, Beijing 100853, China.
Feng CaoDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China ; Department of Cardiology, Chinese PLA General Hospital, Beijing 100853, China.
Air Force Medical University · CNXijing Hospital · CNChinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) have been proposed as a promising cell population for cell therapy and regenerative medicine applications. However, the low retention and poor survival of engrafted cells hampered the therapeutic efficacy of engrafted MSCs. Ghrelin is a 28-amino-acid peptide hormone and is proved to exert a protective effect on the cardiovascular system. This study is designed to investigate the protective effects of ghrelin on engrafted adipose-derived mesenchymal stem cells (ADMSCs) and its beneficial effects with cellular therapy in mice myocardial infarction (MI). Results showed that intramyocardial injection of ADMSCs combining with ghrelin administration inhibited host cardiomyocyte apoptosis, reduced fibrosis, and improved cardiac function. To reveal possible mechanisms, ADMSCs were subjected to hypoxia/serum deprivation (H/SD) injury to simulate ischemic conditions in vivo. Ghrelin (10(-8) M, 33,712 pg/ml) improved ADMSCs survival under H/SD condition. Western blot assay revealed that ghrelin increased AKT phosphorylation both in vivo and in vitro, decreased the proapoptotic protein Bax, and increased the antiapoptotic protein Bcl-2 in vitro, while these effects were abolished by PI3K inhibitor LY294002. These revealed that ghrelin may serve as a promising candidate for hormone-driven approaches to improve the efficacy of mesenchymal stem cell-based therapy for cardiac ischemic disease via PI3K/AKT pathway.

Indexed as

Cell- and Tissue-Based TherapyMesenchymal Stem Cell TransplantationAdipose TissueAnimalsApoptosisbcl-2-Associated X ProteinCell SurvivalGhrelinHumansMesenchymal Stem CellsMiceMyocardial InfarctionMyocardial IschemiaPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal Transductionbcl-2-Associated X ProteinGhrelinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt

Identifiers

PMID25879037
PMCPMC4387976
OpenAlexW2003865551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.